People | February 20, 2022
Resolution Therapeutics strengthens its team with two new appointments
Victor Dillard as VP Corporate Development and Lorna Peers as VP Finance
Victor Dillard as VP Corporate Development and Lorna Peers as VP Finance
Collaboration aims to evolve precision medicine with cell-specific delivery of gene therapy
She holds a Masters degree in Genetics along with a Ph.D. in Biochemistry
Last year, the company's early-stage breast cancer detection test became the first such test to receive the Breakthrough Device Designation
Laglo Soft lotion comes with a unique technology that enhances moisturisation and restructures the skin
The collaboration will leverage EdiGene’s expertise in high-throughput genome editing screening and Neukio’s strength in the development and manufacturing of induced pluripotent stem cell (iPSC) and natural killer cell (NK Cell)
Allocation for the healthcare sector has gone up but is still woefully short of expectations. A few leading voices from the hospital and consulting sectors share their perspective on what they expect from Budget 2022
Optimized for pharma/biopharma to deliver a deeper understanding of cellular function
Phase 1/2 trial of E-602 expected to open in Q1 2022 in patients with solid tumours
CliniSys has the proven ability to deliver 100s of millions of medical results a month to enable pandemic-scale population disease surveillance across the globe
Subscribe To Our Newsletter & Stay Updated
